Nextgen Biomed Ltd
Tel Aviv Stock Exchange NXGN.TA
Nextgen Biomed Ltd Revenue Per Share for the year ending December 31, 2023: USD 0.00
Nextgen Biomed Ltd Revenue Per Share is USD 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Nextgen Biomed Ltd Revenue Per Share for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
-
Nextgen Biomed Ltd Revenue Per Share for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
-
Nextgen Biomed Ltd Revenue Per Share for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
-
Nextgen Biomed Ltd Revenue Per Share for the year ending December 31, 2019 was USD 0.00, a 0.00% change year over year.
Key data
| Date | Revenue Per Share | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NXGN.TA
| CEO | Mr. Harel Hershtik |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | 132 Azrieli Towers Round Building |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Description
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email